Abstract
The minimal length of proximal margin (PM) in esophagogastric junction cancer has not been established yet and its impact on patient survival remains unclear. Pubmed, Embase and Scopus databases were searched for “adenocarcinoma of the esophagogastric junction”, “adenocarcinoma of the gastroesophageal junction” and “cardia cancer”, each combined with “proximal margin”. English written studies that specified PM length in AEG were included. Survival data in relation to PM were extracted. 13 studies, that were all retrospective case series, with a total number of 2648 patients met inclusion criteria and were analyzed. While 93% of 230 patients with Siewert type I had esophagectomy, 69% of 1270 patients with Siewert type II and 93% of 872 patients with Siewert type III had transhiatal extended gastrectomy. Minimal PM length was treated by five studies and ranged between 2 and 6 cm. While three studies defined minimal PM by the necessary length to obtain R0 resection, two studies found minimal PM length significantly associated with survival. Multivariate analyses revealed in two studies an independent impact of PM on survival, whereas one study did not found any significant relation between PM and survival. One study showed that PM length was significantly associated with survival in T2–4N0–2 tumors, but not in T1 or N3 tumors. In conclusion, available retrospective studies did not allow a conclusion for a minimal length of PM and showed no clear evidence for an impact of PM length on survival. Taking into consideration available data and the shrinkage phenomen, a PM > 2 cm might be necessary to obtain a sufficient PM.
Similar content being viewed by others
References
Correa P, Chen VW (1994) Gastric cancer. Cancer Surv 19–20:55–76
Devesa SS, Blot WJ, Fraumeni JF (1998) Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83:2049–2053
Bollschweiler E, Wolfgarten E, Gutschow C, Hölscher AH (2001) Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 92:549–555
Steevens J, Botterweck AA, Dirx MJ, van der Brandt PA, Schouten LJ (2010) Trends in incidence of oesophageal and stomach cancer subtypes in Europe. Eur J Gastroenterol Hepatol 22:669–678. https://doi.org/10.1097/MEG.0b013e32832ca091
Siewert JR, Hölscher AH, Becker K, Gössner W (1987) Cardia cancer: attempt at a therapeutically relevant classification. Chirurg 58:25–32
Rice TW, Ishwaran H, Ferguson MK, Blackstone EH, Goldstraw P (2017) Cancer of the esophagus and esophagogastric junction: an eigth edition staging primer. J Thorac Oncol 12:36–42
Mariette C, Piessen G, Briez N, Gronnier C, Triboulet JP (2011) Oesophagogastric junction adenocarcinoma: which therapeutic approach? Lancet Oncol 12:296–305. https://doi.org/10.1016/S1470-2045(10)70125-X
Mattioli S, Di Simone MP, Ferruzzi L, D’Ovidio F, Pilotti V, Carella R et al (2001) Surgical therapy for adenocarcinoma of the cardia: modalities of recurrence and extension of resection. Dis Esophagus 14:104–109
Mariette C, Castel B, Balon JM, Van Seuningen I, Triboulet JP (2003) Extent of oesophageal resection for adenocarcinoma of the oesophagogastric junction. Eur J Surg Oncol 29:588–593. https://doi.org/10.1016/S0748-7983(03)00109-4
https://www.cebm.net/2009/06/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/. Accessed 24 June 2019
Siu KF, Cheung HC, Wong J (1986) Shrinkage of the esophagus after resection for carcinoma. Ann Surg 203:173–176
Mine S, Sano T, Hiki N, Yamada K, Kosuga T, Nunobe S et al (2013) Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction. Br J Surg 100:1050–1054. https://doi.org/10.1002/bjs.9170
Feng F, Tian Y, Xu G, Liu S, Liu Z, Zheng G et al (2016) The length of proximal margin does not influence the prognosis of Siewert type II/III adenocarcinoma of esophagogastric junction after transhiatal curative gastrectomy. Springerplus 5:588–593. https://doi.org/10.1186/s40064-016-2240-3
Barbour AP, Rizk NP, Gonen M, Tang L, Bains MS, Rusch VW et al (2007) Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome. Ann Surg 246:1–8. https://doi.org/10.1097/01.sla.0000255563.65157.d2
Kinoshita T, Gotohda N, Kato Y, Takahashi S, Konishi M, Okazumi S et al (2012) Laparoscopic transhiatal resection for Siewert type II adenocarcinoma of the esophagogastric junction: operative technique and initial results. Surg Laparosc Endosc Percut Tech 22:e199–e203. https://doi.org/10.1097/SLE.0b013e31825a72e2
Papachristou DN, Fortner JG (1980) Adenocarcinoma of the gastric cardia. The choice of gastrectomy. Ann Surg 192:58–64
Tsujitani S, Okuyama T, Orita H, Kakeji Y, Maehara Y, Sugimachi K et al (1995) Margins of resection of the esophagus for gastric cancer with esophageal invasion. Hepatogastroenterology 42:873–877
Ito H, Clancy TE, Osteen RT, Swanson RS, Bueno R, Sugarbaker DJ et al (2004) Adenocarcinoma of the gastric cardia: what is the optimal surgical approach? J Am Coll Surg 199:880–886. https://doi.org/10.1016/j.jamcollsurg.2004.08.015
Shen JG, Cheong JH, Hyung WJ, Kim J, Choi SH, Noh SH (2006) Influence of a microscopic positive proximal margin in the treatment of gastric adenocarcinoma of the cardia. World J Gastroenterol 12:3883–3886
Lee IS, Ahn JY, Yook JH, Kim BS (2017) Mediastinal lymph node dissection and distal esophagectomy is not essential in early esophagogastric junction adenocarcinoma. World J Surg Oncol 15:28–35. https://doi.org/10.1186/s12957-016-1088-x
Duan XF, Yue J, Tang P, Shang XB, Jiang HJ, Yu ZT (2017) Lymph node dissection for Siewert II esophagogastric junction adenocarcinoma: a retrospective study of 3 surgical procedures. Medicine (Baltimore) 96:7–12. https://doi.org/10.1097/MD.0000000000006120
Sugita S, Kinoshita T, Kaito A, Watanabe M, Sunagawa H (2018) Short-term outcomes after laparoscopic versus open transhiatal resection of Siewert type II adenocarcinoma of the esophagogastric junction. Surg Endosc 32:383–390. https://doi.org/10.1007/s00464-017-5687-6
Johansson J, Djerf P, Oberg S, Zilling T, von Holstein CS, Johnsson F et al (2008) Two different surgical approaches in the treatment of adenocarcinoma at the gastroesophageal junction. World J Surg 32:1013–1020. https://doi.org/10.1007/s00268-008-9470-7
Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. NEJM 355:11–20. https://doi.org/10.1056/NEJMoa055531
Ychou M, Boige V, Pignon JP, Conroy T, Bouché O, Lebreton G et al (2011) Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol 29:1715–1721. https://doi.org/10.1200/JCO.2010.33.0597
Giacopuzzi S, Bencivenga M, Weindelmayer J, Verlato G, de Manzoni G (2017) Western strategy for EGJ carcinoma. Gastric Cancer 20:S60–S68. https://doi.org/10.1007/s10120-016-0685-2
Suh YS, Han DS, Kong SH, Lee HJ, Kim YT, Kim WH et al (2012) Should adenocarcinoma of the esophagogastric junction be classified as esophageal cancer? A comparative analysis according to the seventh AJCC TNM classification. Ann Surg 255:908–915. https://doi.org/10.1097/SLA.0b013e31824beb95
Reynolds JV, Ravi N, Muldoon C, Larkin JO, Rowley S, O’Byrne K et al (2010) Differential pathologic variables and outcomes across the spectrum of adenocarcinoma of the esophagogastric junction. World J Surg 34:2821–2829. https://doi.org/10.1007/s00268-010-0738-y
Haverkamp L, Ruurda JP, van Leeuwen MS, Siersema PD, van Hillegersberg R (2014) Systematic review of the surgical strategies of adenocarcinomas of the gastroesophageal junction. Surg Oncol 23:222–228. https://doi.org/10.1016/j.suronc.2014.10.004
Kauppila JH, Wahlin K, Lagergren J (2017) Gastrectomy compared to oesophagectomy for Siewert II and III gastro-oesophageal junctional cancer in relation to resection margins, lymphadenectomy and survival. Sci Rep 7:17783–17788. https://doi.org/10.1038/s41598-017-18005-6
Parry J, Haverkamp L, Bruijnen RC, Siersema PD, Ruurda JP, van Hillegersberg R (2015) Surgical treatment of adenocarcinomas of the gastro-esophageal junction. Ann Surg Oncol 22:597–603. https://doi.org/10.1245/s10434-014-4047-1
Martin JT, Mahan A, Zwischenberger JB, McGrath PC, Tzeng CW (2015) Should gastric cardia cancers be treated with esophagectomy or total gastrectomy? A comprehensive analysis of 4,996 NSQIP/SEER patients. J Am Coll Surg 220:510–520. https://doi.org/10.1016/j.jamcollsurg.2014.12.024
Blank S, Schmidt T, Heger P, Strowitzki MJ, Sisic L, Heger U et al (2018) Surgical strategies in true adenocarcinoma of the esophagogastric junction (AEG II): thoracoabdominal or abdominal approach? Gastric Cancer 21:303–314. https://doi.org/10.1007/s10120-017-0746-1
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Minoa Jung received a fellowship grant from Johnson & Johnson and Intuitive Surgical. The other authors declare that they have no conflicts of interest.
Human rights and animal participants
Research of this article does not involve human participants or animals.
Informed consent
For this kind of study, formal consent is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Niclauss, N., Jung, M.K., Chevallay, M. et al. Minimal length of proximal resection margin in adenocarcinoma of the esophagogastric junction: a systematic review of the literature. Updates Surg 71, 401–409 (2019). https://doi.org/10.1007/s13304-019-00665-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13304-019-00665-w